Bendamustine and Rituximab in Combination With Copanlisib for the Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Clinical trial NCT04155840 · TERMINATED
Trial details
- NCT number
- NCT04155840
- Sponsor
- University of Washington
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-31
- Primary completion
- 2021-03-16
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.